Biocept (BIOCQ) Stock Statistics & Valuation Metrics

Biocept has a market cap or net worth of $263.00. The enterprise value is -$337.21K.

Biocept has 2,626,026 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biocept’s return on equity (ROE) is -3.62 and return on invested capital (ROIC) is -117.56%.

The current PE Ratio of Biocept is ―. Biocept’s PEG ratio is -0.00010.

In the last 12 months, Biocept had revenue of 25.86M and earned -32.09M in profits. Earnings per share was -56.78.

In the last 12 months, operating cash flow was -17.60M and capital expenditures -680.00K, giving a free cash flow of -18.28M billion.

Biocept pays an annual dividend of ―, resulting in a dividend yield of ―

Biocept upcoming earnings date is Aug 12, 2024, After Close (Confirmed).

Biocept as a current ratio of 2.97, with Debt / Equity ratio of 136.67%

In the past 12 months, Biocept has paid -125.00K in taxes.

Biocept EV to EBITDA ratio is -0.07, with an EV/FCF ratio of -0.16.

Biocept has $6.63M in cash and marketable securities with $11.59M in debt, giving a net cash position of -$4.96M billion.

Gross margin is -9.99%, with operating margin of -123.69%, and net profit margin of -124.09%.

The average price target for Biocept is ―, which is 11.43% higher than the current price. The consensus rating is ―